Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
NCT07272837
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Obesity
Semaglutide
GLP-1
Diabetes
Sponsor
University of Alberta